OMA Guidelines Bundle

Obesity-Related Diseases 2026

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1544298

Contents of this Issue

Navigation

Page 1 of 45

2 Description of Conditions KEY POINTS: Obtaining History of Weight-Related Metabolic and Biomechanical Complications 1. Adiposopathy, or "sick fat," refers to dysfunctional adipose tissue that contributes to metabolic diseases, including type 2 diabetes, high blood pressure, and cardiovascular disease. 2. Fat mass disease refers to the negative health effects of excess adipose tissue effecting body systems including joint stress, airway compression, and/or organ compression. 3. Many complications of obesity have traditionally been attributed to either "sick fat" or "fat mass" disease. However, emerging evidence shows that these processes are closely interconnected and often co-occur. 4. Chronic, low-grade inflammation is a pervasive pathophysiologic mechanism in almost all complications of obesity. 5. Adiposopathy can contribute to increased pain, which may lead to greater functional disability. 6. Excess adipose tissue may obscure typical physical examination findings in complications that present as masses. When obtaining a history of weight-related conditions, a thorough review of systems should be conducted to identify these conditions. 7. Screening for complications and comorbidities in patients with obesity does not differ from that for patients without obesity; however, clinicians should remain alert for atypical presentations of weight-related complications. 8. A thorough history should include current and past symptoms, weight trajectory, mental health conditions, and functional limitations.

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity-Related Diseases 2026